Hamm John M. 4
4 · CUMBERLAND PHARMACEUTICALS INC · Filed Mar 26, 2024
Insider Transaction Report
Form 4
Hamm John M.
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2024-03-23$1.81/sh−445$805→ 26,003 total - Award
Options (right to buy)
2024-03-25$1.71/sh+5,500$9,405→ 12,500 totalExercise: $1.71From: 2028-03-25Exp: 2034-03-25→ Common Stock (5,500 underlying)